Medical Advocates
Ethics and Infectious Diseases
  Ethical Challenges
Screening/Testing
 Refusal of Care/Services
Detention
Patient Exploitation
Compulsory Treatment
Decision-Making
Reproduction
Transplants
End-of-Life Care
Enteral Nutrition
Professional Associations
National Challenges         Sterilization
Bioterrorism                     Prison Challenges
 HIV Exceptionalism           Conflicts of Interest
Pharmaceutical Industry   Pregnancy
HIV Prevention   
Stigma
 Physician Reimbursement 
Ethics and Disease Challenges and Duties
 HIV Cure
 Ebola Virus Disease
 Executions






 
Ethics Main Page Main New and Noteworthy Home Page

Medical Advocates
Pegylated Interferon alfa-2a (Pegasys)
 
HCV Indications

New and Noteworthy      HIV/HCV Coinfection
 General Reports             Children
 Pharmacokinetics          Pharmacoeconomics 
Viral Dynamics
 Diagnostics
 Efficacy
 Adverse Events
 Transplants
 Treatment Strategies
Discontinuation of Therapy
Special Populations
Quality of Life

  
Peg Inf alfa 2a Main Main New/Newsworthy  Home Page
Last Update:  March 25, 2015
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     
March 2015
      
General Reports